Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DISHMAN PHARMA BIOCON /
DISHMAN PHARMA
 
P/E (TTM) x 19.7 30.0 65.7% View Chart
P/BV x 1.8 3.3 53.9% View Chart
Dividend Yield % 0.6 0.7 85.4%  

Financials

 BIOCON    DISHMAN PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-23
DISHMAN PHARMA
Mar-16
BIOCON /
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs388374 103.6%   
Low Rs192129 148.6%   
Sales per share (Unadj.) Rs93.1197.0 47.2%  
Earnings per share (Unadj.) Rs5.421.2 25.3%  
Cash flow per share (Unadj.) Rs14.634.7 42.1%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Avg Dividend yield %0.50.8 65.1%  
Book value per share (Unadj.) Rs146.5179.9 81.5%  
Shares outstanding (eoy) m1,200.6080.70 1,487.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.11.3 243.7%   
Avg P/E ratio x54.111.9 455.5%  
P/CF ratio (eoy) x19.87.3 273.1%  
Price / Book Value ratio x2.01.4 141.3%  
Dividend payout %28.09.4 296.7%   
Avg Mkt Cap Rs m347,81420,307 1,712.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,8105,355 407.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,74215,898 702.9%  
Other income Rs m7,681265 2,894.1%   
Total revenues Rs m119,42316,163 738.9%   
Gross profit Rs m16,6114,103 404.8%  
Depreciation Rs m11,1311,091 1,020.6%   
Interest Rs m4,190944 443.7%   
Profit before tax Rs m8,9712,334 384.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,541624 407.5%   
Profit after tax Rs m6,4301,710 376.0%  
Gross profit margin %14.925.8 57.6%  
Effective tax rate %28.326.7 106.0%   
Net profit margin %5.810.8 53.5%  
BALANCE SHEET DATA
Current assets Rs m123,34011,018 1,119.5%   
Current liabilities Rs m85,1079,517 894.3%   
Net working cap to sales %34.29.4 362.4%  
Current ratio x1.41.2 125.2%  
Inventory Days Days12957 226.3%  
Debtors Days Days1173 3,337.3%  
Net fixed assets Rs m394,07818,787 2,097.6%   
Share capital Rs m6,003161 3,719.3%   
"Free" reserves Rs m169,92614,354 1,183.8%   
Net worth Rs m175,92914,516 1,212.0%   
Long term debt Rs m152,9054,189 3,649.8%   
Total assets Rs m517,41829,805 1,736.0%  
Interest coverage x3.13.5 90.5%   
Debt to equity ratio x0.90.3 301.1%  
Sales to assets ratio x0.20.5 40.5%   
Return on assets %2.18.9 23.0%  
Return on equity %3.711.8 31.0%  
Return on capital %4.017.5 22.8%  
Exports to sales %3.124.9 12.5%   
Imports to sales %6.03.7 159.3%   
Exports (fob) Rs m3,4673,956 87.6%   
Imports (cif) Rs m6,654594 1,119.6%   
Fx inflow Rs m3,4674,952 70.0%   
Fx outflow Rs m6,654697 955.1%   
Net fx Rs m-3,1874,255 -74.9%   
CASH FLOW
From Operations Rs m18,5252,786 664.8%  
From Investments Rs m-142,818-1,529 9,341.2%  
From Financial Activity Rs m130,487-941 -13,866.8%  
Net Cashflow Rs m6,411317 2,025.6%  

Share Holding

Indian Promoters % 40.4 61.4 65.7%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 23.0 91.8%  
FIIs % 6.6 12.0 54.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 38.6 102.0%  
Shareholders   434,339 52,291 830.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Dishman Pharma Share Price Performance

Period Biocon Dishman Pharma S&P BSE HEALTHCARE
1-Day 3.04% 2.87% 1.18%
1-Month -2.42% -2.45% -0.75%
1-Year 30.66% 96.38% 61.82%
3-Year CAGR -13.51% 89.34% 18.16%
5-Year CAGR -2.70% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Biocon, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.